Blood Collection Device Validation for Patients on Blood Thinners
Recruiting0 awards4 criteria
Berkeley, California
This trial is for a medical device manufacturer to qualify their line of blood collection tubes with the FDA. Participants who are currently on anticoagulants will be compensated for their time and resources.
Transcranial Direct Current Stimulation
tDCS for Post-Stroke Neglect
Recruiting0 awards4 criteria
Charleston, South Carolina
This trial will test a new intervention for post-stroke neglect, which combines repetitive task-specific practice with transcranial direct current stimulation. The goal is to establish a more comprehensive neglect measure.
Behavioural Intervention
Augmented Visual Feedback for Stroke Rehabilitation
Recruiting1 award3 criteria
Chicago, Illinois
This trial will study the feasibility and effects of error-augmented visual feedback during motion tracking with a Leap Motion device and the LookingGlass for people with different levels of stroke severity.
Popular Filters
Trials for Hemorrhagic Stroke Patients
EMR-Based Treatment for Neurological Disorders
Recruiting3 awardsPhase 4
Evanston, Illinois
This trial will study 10 common neurological disorders at NorthShore University HealthSystem using electronic medical records (EMR). They aim to show that assigning treatments based on specific subgroups, obtaining electronic consent
Anticoagulant
Anticoagulation for Atrial Fibrillation Post-Ablation
Recruiting3 awardsPhase 4
Calgary, Alberta
This trial is comparing medical approaches for stroke prevention in people who have atrial fibrillation (AF) and have undergone a successful procedure called ablation to eliminate or substantially reduce the arrhythmia.
Exoskeleton
Robot-assisted Training with the H2 Exoskeleton for Stroke
Recruiting1 award9 criteria
Houston, Texas
This trial will compare the use of a smart lower limb robotic exoskeleton for rehabilitation after stroke with supervised motor practice. Additionally, it will examine the use of noninvasive scalp electroencephalography (EEG) to learn specific brain wave patterns associated with learning to walk on the powered lower limb exoskeleton.
Trials for Ischemic Stroke Patients
EMR-Based Treatment for Neurological Disorders
Recruiting3 awardsPhase 4
Evanston, Illinois
This trial will study 10 common neurological disorders at NorthShore University HealthSystem using electronic medical records (EMR). They aim to show that assigning treatments based on specific subgroups, obtaining electronic consent
Anticoagulant
Anticoagulation for Atrial Fibrillation Post-Ablation
Recruiting3 awardsPhase 4
Calgary, Alberta
This trial is comparing medical approaches for stroke prevention in people who have atrial fibrillation (AF) and have undergone a successful procedure called ablation to eliminate or substantially reduce the arrhythmia.
Exoskeleton
Robot-assisted Training with the H2 Exoskeleton for Stroke
Recruiting1 award9 criteria
Houston, Texas
This trial will compare the use of a smart lower limb robotic exoskeleton for rehabilitation after stroke with supervised motor practice. Additionally, it will examine the use of noninvasive scalp electroencephalography (EEG) to learn specific brain wave patterns associated with learning to walk on the powered lower limb exoskeleton.
Trials With No Placebo
EMR-Based Treatment for Neurological Disorders
Recruiting3 awardsPhase 4
Evanston, Illinois
This trial will study 10 common neurological disorders at NorthShore University HealthSystem using electronic medical records (EMR). They aim to show that assigning treatments based on specific subgroups, obtaining electronic consent
Anticoagulant
Anticoagulation for Atrial Fibrillation Post-Ablation
Recruiting3 awardsPhase 4
Calgary, Alberta
This trial is comparing medical approaches for stroke prevention in people who have atrial fibrillation (AF) and have undergone a successful procedure called ablation to eliminate or substantially reduce the arrhythmia.
Exoskeleton
Robot-assisted Training with the H2 Exoskeleton for Stroke
Recruiting1 award9 criteria
Houston, Texas
This trial will compare the use of a smart lower limb robotic exoskeleton for rehabilitation after stroke with supervised motor practice. Additionally, it will examine the use of noninvasive scalp electroencephalography (EEG) to learn specific brain wave patterns associated with learning to walk on the powered lower limb exoskeleton.
Neurostimulation Device
Brain Stimulation for Stroke Recovery
Recruiting1 award8 criteria
Madison, Wisconsin
This trial tests if stimulating arm muscles and sending gentle electrical signals through the tongue can help stroke patients recover better. It targets adults who have trouble moving their arms and hands after a stroke. The treatment uses a brain-computer system to help retrain the brain and muscles to work together.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.